Abnormal interaction of oligomeric amyloid-β with phosphorylated tau: Implications to synaptic dysfunction and neuronal damage

Maria Manczak, P (Hemachandra) Reddy

    Research output: Contribution to journalArticle

    39 Citations (Scopus)

    Abstract

    Alzheimer's disease (AD) is a progressive neurodegenerative mental illness characterized by memory loss, multiple cognitive impairments, and changes in personality and behavior. The purpose of our study was to determine the interaction between monomeric and oligomeric amyloid-β (Aβ) and phosphorylated tau in AD neurons. Using postmortem brains from AD patients at different stages of disease progression and control subjects, and also from AβPP, AβPPxPS1, and 3xTg-AD mice, we studied the physical interaction between Aβ and phosphorylated tau. Using immunohistological and double-immunofluorescence analyses, we also studied the localization of monomeric and oligomeric Aβ with phosphorylated tau. We found monomeric and oligomeric Aβ interacted with phosphorylated tau in neurons affected by AD. Further, these interactions progressively increased with the disease process. These findings led us to conclude that Aβ interacts with phosphorylated tau and may damage neuronal structure and function, particularly synapses, leading to cognitive decline in AD patients. Our findings suggest that binding sites between Aβ and phosphorylated tau need to be identified and molecules developed to inhibit this interaction.

    Original languageEnglish (US)
    Pages (from-to)285-295
    Number of pages11
    JournalJournal of Alzheimer's Disease
    Volume36
    Issue number2
    DOIs
    StatePublished - 2013

    Fingerprint

    Amyloid
    Alzheimer Disease
    Neurons
    Memory Disorders
    Brain Diseases
    Synapses
    Fluorescent Antibody Technique
    Personality
    Disease Progression
    Binding Sites

    Keywords

    • Amyloid-β
    • amyloid-β protein precursor
    • cognitive decline
    • phosphorylated tau
    • synapses

    ASJC Scopus subject areas

    • Psychiatry and Mental health
    • Geriatrics and Gerontology
    • Clinical Psychology

    Cite this

    Abnormal interaction of oligomeric amyloid-β with phosphorylated tau : Implications to synaptic dysfunction and neuronal damage. / Manczak, Maria; Reddy, P (Hemachandra).

    In: Journal of Alzheimer's Disease, Vol. 36, No. 2, 2013, p. 285-295.

    Research output: Contribution to journalArticle

    @article{074f87c59dfa4415a2c6c6fd9bdebd8f,
    title = "Abnormal interaction of oligomeric amyloid-β with phosphorylated tau: Implications to synaptic dysfunction and neuronal damage",
    abstract = "Alzheimer's disease (AD) is a progressive neurodegenerative mental illness characterized by memory loss, multiple cognitive impairments, and changes in personality and behavior. The purpose of our study was to determine the interaction between monomeric and oligomeric amyloid-β (Aβ) and phosphorylated tau in AD neurons. Using postmortem brains from AD patients at different stages of disease progression and control subjects, and also from AβPP, AβPPxPS1, and 3xTg-AD mice, we studied the physical interaction between Aβ and phosphorylated tau. Using immunohistological and double-immunofluorescence analyses, we also studied the localization of monomeric and oligomeric Aβ with phosphorylated tau. We found monomeric and oligomeric Aβ interacted with phosphorylated tau in neurons affected by AD. Further, these interactions progressively increased with the disease process. These findings led us to conclude that Aβ interacts with phosphorylated tau and may damage neuronal structure and function, particularly synapses, leading to cognitive decline in AD patients. Our findings suggest that binding sites between Aβ and phosphorylated tau need to be identified and molecules developed to inhibit this interaction.",
    keywords = "Amyloid-β, amyloid-β protein precursor, cognitive decline, phosphorylated tau, synapses",
    author = "Maria Manczak and Reddy, {P (Hemachandra)}",
    year = "2013",
    doi = "10.3233/JAD-130275",
    language = "English (US)",
    volume = "36",
    pages = "285--295",
    journal = "Journal of Alzheimer's Disease",
    issn = "1387-2877",
    publisher = "IOS Press",
    number = "2",

    }

    TY - JOUR

    T1 - Abnormal interaction of oligomeric amyloid-β with phosphorylated tau

    T2 - Implications to synaptic dysfunction and neuronal damage

    AU - Manczak, Maria

    AU - Reddy, P (Hemachandra)

    PY - 2013

    Y1 - 2013

    N2 - Alzheimer's disease (AD) is a progressive neurodegenerative mental illness characterized by memory loss, multiple cognitive impairments, and changes in personality and behavior. The purpose of our study was to determine the interaction between monomeric and oligomeric amyloid-β (Aβ) and phosphorylated tau in AD neurons. Using postmortem brains from AD patients at different stages of disease progression and control subjects, and also from AβPP, AβPPxPS1, and 3xTg-AD mice, we studied the physical interaction between Aβ and phosphorylated tau. Using immunohistological and double-immunofluorescence analyses, we also studied the localization of monomeric and oligomeric Aβ with phosphorylated tau. We found monomeric and oligomeric Aβ interacted with phosphorylated tau in neurons affected by AD. Further, these interactions progressively increased with the disease process. These findings led us to conclude that Aβ interacts with phosphorylated tau and may damage neuronal structure and function, particularly synapses, leading to cognitive decline in AD patients. Our findings suggest that binding sites between Aβ and phosphorylated tau need to be identified and molecules developed to inhibit this interaction.

    AB - Alzheimer's disease (AD) is a progressive neurodegenerative mental illness characterized by memory loss, multiple cognitive impairments, and changes in personality and behavior. The purpose of our study was to determine the interaction between monomeric and oligomeric amyloid-β (Aβ) and phosphorylated tau in AD neurons. Using postmortem brains from AD patients at different stages of disease progression and control subjects, and also from AβPP, AβPPxPS1, and 3xTg-AD mice, we studied the physical interaction between Aβ and phosphorylated tau. Using immunohistological and double-immunofluorescence analyses, we also studied the localization of monomeric and oligomeric Aβ with phosphorylated tau. We found monomeric and oligomeric Aβ interacted with phosphorylated tau in neurons affected by AD. Further, these interactions progressively increased with the disease process. These findings led us to conclude that Aβ interacts with phosphorylated tau and may damage neuronal structure and function, particularly synapses, leading to cognitive decline in AD patients. Our findings suggest that binding sites between Aβ and phosphorylated tau need to be identified and molecules developed to inhibit this interaction.

    KW - Amyloid-β

    KW - amyloid-β protein precursor

    KW - cognitive decline

    KW - phosphorylated tau

    KW - synapses

    UR - http://www.scopus.com/inward/record.url?scp=84879656519&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84879656519&partnerID=8YFLogxK

    U2 - 10.3233/JAD-130275

    DO - 10.3233/JAD-130275

    M3 - Article

    C2 - 23594602

    AN - SCOPUS:84879656519

    VL - 36

    SP - 285

    EP - 295

    JO - Journal of Alzheimer's Disease

    JF - Journal of Alzheimer's Disease

    SN - 1387-2877

    IS - 2

    ER -